The company was founded in 1997 and listed on the Shanghai Stock Exchange in 2001; it also introduced state-owned capital and powerful industry investors in 2021, becoming an enterprise actually controlled by Guangdong Shennong Enterprise Management Partnership (Limited Partnership). Adhering to the business philosophy of “New Kangmei, Health and Beauty”, the company insists on focusing on the main business and continuing to consolidate the layout of the entire traditional Chinese medicine industry chain; with traditional Chinese medicine tablets as the core and smart pharmacy as the starting point, the company promotes the implementation of five major projects, including the national demonstration of smart pharmacy standardization, and comprehensively builds an “big health+big platform+big data+big service” system to further build an influential “smart +” health industry enterprise with accurate service for the entire traditional Chinese medicine industry chain. The company takes the production and sales of Chinese medicine tablets as the core, and implements an integrated operation model for the entire traditional Chinese medicine industry chain. The business system covers upstream cultivation of authentic Chinese herbal medicines, fresh processing and resource integration; midstream Chinese herbal medicine specialty market management, production and sales of Chinese herbal medicines, health food, chemicals and medical devices; and a comprehensive multi-level marketing network integrating downstream medical institution resources, smart pharmacies, OTC retail, chain pharmacies, direct sales, pharmaceutical e-commerce, and mobile medical care. The company's main products include Chinese medicine tablets, proprietary Chinese medicines, chemicals, health food and food. Corporate honors: “Jieyang City Caring Donor Enterprise to Fight COVID-19”, the company became one of the top 2000 global enterprises, the top 500 Chinese enterprises, the most valuable investment listed company, China's 50 most respected listed companies, China's top ten pharmaceutical industry, the top ten pharmaceutical companies with the highest brand competitiveness in China, the top 100 enterprises in Guangdong tax, and the “2023 National Intellectual Property Demonstration Enterprise” honorary medal. It is the only enterprise in Jieyang City to receive the “National Intellectual Property Demonstration Enterprise” award in 2023.